Quick Answer
CONMED Corp reported Diluted EPS of $1.51 per share for fiscal year 2025.
CONMED Corp Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $1.51 | -64.5% |
| 2024 | $4.25 | +108.3% |
| 2023 | $2.04 | +176.1% |
| 2022 | -$2.68 | -238.1% |
| 2021 | $1.94 | +506.2% |
| 2020 | $0.32 | -67.0% |
| 2019 | $0.97 | -31.2% |
| 2018 | $1.41 | -28.4% |
| 2017 | $1.97 | +278.8% |
| 2016 | $0.52 | -52.3% |
| 2015 | $1.09 | -6.0% |
| 2014 | $1.16 | -9.4% |
| 2013 | $1.28 | -9.2% |
| 2012 | $1.41 | +4600.0% |
| 2011 | $0.03 | -97.1% |
| 2010 | $1.05 | +150.0% |
| 2009 | $0.42 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.09 | -94.3% | -87.0% |
| June 30, 2025 | $0.69 | -28.1% | +263.2% |
| March 31, 2025 | $0.19 | -69.8% | -87.9% |
| September 30, 2024 | $1.57 | +214.0% | +63.5% |
| June 30, 2024 | $0.96 | +123.3% | +52.4% |
| March 31, 2024 | $0.63 | +950.0% | +26.0% |
| September 30, 2023 | $0.50 | -66.2% | +16.3% |
| June 30, 2023 | $0.43 | +107.6% | +616.7% |
- CONMED Corp showed a decrease of -64.5% in Diluted EPS compared to the prior fiscal year.
- Over the 2009–2025 period, CONMED Corp’s diluted eps has grown by 259.5% (from $0.42 per share to $1.51 per share).
- The most recent figure is from CONMED Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: